In addition, a retrospective analysis showed a highly significant reduction in incidence of lung cancers in patients receiving the two higher doses of canakinumab (Ridker et al., 2017 ).
← all excerpts
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
1
—
—